Malathi, D. C., Janakiraman, K., Thangavelu, S. V. A., & Ravichandran, D. (2026). Enlicitide (Lipfendra): the first oral PCSK9 inhibitor - from macrocyclic peptide innovation to clinical translation. International Journal of Basic & Clinical Pharmacology, 15(5), 1126–1134. https://doi.org/10.18203/2319-2003.ijbcp20262890